Long-term prognostic significance of history of cancer and atrial fibrillation in coronary artery disease

Darby, 2003, Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women, BMJ, 326, 256, 10.1136/bmj.326.7383.256 Falanga, 2013, Coagulation and cancer: biological and clinical aspects, J. Thromb. Haemost., 11, 223, 10.1111/jth.12075 Bertero, 2018, Linking Heart Failure to Cancer: Background Evidence and Research Perspectives, Circulation, 138, 735, 10.1161/CIRCULATIONAHA.118.033603 Yuan, 2019, Association of Cancer and the Risk of Developing Atrial Fibrillation: A Systematic Review and Meta-Analysis, Cardiol. Res. Pract., 2019, 8985273, 10.1155/2019/8985273 Menichelli, 2021, Cancer and atrial fibrillation: Epidemiology, mechanisms, and anticoagulation treatment, Prog. Cardiovasc. Dis., 66, 28, 10.1016/j.pcad.2021.04.004 Darby, 2013, Risk of ischemic heart disease in women after radiotherapy for breast cancer, N. Engl. J. Med., 368, 987, 10.1056/NEJMoa1209825 Yakupovich, 2020, Heart dose and coronary artery calcification in patients receiving thoracic irradiation for lung cancer, J. Thorac. Dis., 12, 223, 10.21037/jtd.2020.01.52 Kwak, 2020, De novo malignancy risk in patients undergoing the first percutaneous coronary intervention: A nationwide population-based cohort study, Int. J. Cardiol., 313, 25, 10.1016/j.ijcard.2020.04.085 Shiba, 2011, Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan–first report from the CHART-2 study, Circ J, 75, 823, 10.1253/circj.CJ-11-0135 Tsuji, 2017, Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study, Eur. J. Heart Fail., 19, 1258, 10.1002/ejhf.807 Schulman, 2005, Subcommittee on Control of Anticoagulation of the S, Standardization Committee of the International Society on T, Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients, J. Thromb. Haemost., 3, 692, 10.1111/j.1538-7836.2005.01204.x Lateef, 2020, Atrial fibrillation and cancer; understanding the mysterious relationship through a systematic review, J. Community Hosp. Int. Med. Perspect., 10, 127 Leiva, 2021, Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis: JACC: CardioOncology State-of-the-Art Review, JACC CardioOncol, 3, 619, 10.1016/j.jaccao.2021.08.011 Kattelus, 2018, Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study), PLoS One, 13, e0205454, 10.1371/journal.pone.0205454 Jakobsen, 2019, Incidence of atrial fibrillation in different major cancer subtypes: a Nationwide population-based 12 year follow up study, BMC Cancer, 19, 1105, 10.1186/s12885-019-6314-9 Conen, 2016, Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation, JAMA Cardiol., 1, 389, 10.1001/jamacardio.2016.0280 Ostenfeld, 2014, Atrial fibrillation as a marker of occult cancer, PLoS One, 9, e102861, 10.1371/journal.pone.0102861 Li, 2022, Coronary Atherosclerotic Disease and Cancer: Risk Factors and Interrelation, Front. Cardiovasc. Med., 9 Ball, 2019, Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week, J. Am. Coll. Cardiol., 74, 1714, 10.1016/j.jacc.2019.07.079 Koelwyn, 2020, Myocardial infarction accelerates breast cancer via innate immune reprogramming, Nat. Med., 26, 1452, 10.1038/s41591-020-0964-7 Ording, 2017, Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population-based cohort study, Cancer Med., 6, 1165, 10.1002/cam4.1054 P. Kirchhof, S. Benussi, D. Kotecha, A. Ahlsson, D. Atar, B. Casadei, M. Castella, H.C. Diener, H. Heidbuchel, J. Hendriks, G. Hindricks, A.S. Manolis, J. Oldgren, B.A. Popescu, U. Schotten, B. Van Putte, P. Vardas, Group ESCSD. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 37(38) (2016) 2893–2962. Yasuda, 2018, Atrial fibrillation and ischemic events with rivaroxaban in patients with stable coronary artery disease (AFIRE): Protocol for a multicenter, prospective, randomized, open-label, parallel group study, Int. J. Cardiol., 265, 108, 10.1016/j.ijcard.2018.04.131 Yasuda, 2019, Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease, N. Engl. J. Med., 381, 1103, 10.1056/NEJMoa1904143